The paired-box homeodomain transcription factor Pax6 binds to the upstream region of the TRAP gene promoter and suppresses receptor activator of NF-κB ligand (RANKL)-induced Osteoclast differentiation

Journal of Biological Chemistry

Volumn 288, Issue 43, 2013, Pages 31299-31312

  Kogawa, Masakazu ^a,b   Hisatake, Koji ^a,c   Atkins, Gerald J ^b   Findlay, David M ^b   Enoki, Yuichiro ^a   Sato, Tsuyoshi ^a   Gray, Peter C ^d   Kanesaki Yatsuka, Yukiko ^a   Anderson, Paul H ^e   Wada, Seiki ^a   Kato, Naoki ^a   Fukuda, Aya ^a,c   Katayama, Shigehiro ^a   Tsujimoto, Masafumi ^f   Yoda, Tetsuya ^a   Suda, Tatsuo ^a   Okazaki, Yasushi ^a   Matsumoto, Masahito ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^e UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^f TEIKYO HEISEI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTROPHORETIC MOBILITY SHIFT; HOMEODOMAIN TRANSCRIPTION FACTOR; NEGATIVE REGULATORS; NUCLEAR FACTOR OF ACTIVATED T-CELLS; OSTEOCLAST DIFFERENTIATION; OSTEOCLAST FORMATION; REGULATORY CIRCUITS; REGULATORY FACTORS;

ANTIBIOTICS; BONE; ELECTROPHORETIC MOBILITY; GENES; GLYCOPROTEINS; PHOSPHATASES; TRANSCRIPTION FACTORS;

LIGANDS;

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN GRG6; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR PAX6; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMUR; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENETIC TRANSFECTION; IMMUNOFLUORESCENCE; MACROPHAGE; MOUSE; NONHUMAN; OSTEOCLAST; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRAP GENE; WESTERN BLOTTING;

DIFFERENTIATION; GENE REGULATION; MACROPHAGES; OSTEOCLAST; PAX6; TRANSCRIPTION FACTORS; TRAP;

ACID PHOSPHATASE; ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; EYE PROTEINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HOMEODOMAIN PROTEINS; HUMANS; ISOENZYMES; MICE; NFATC TRANSCRIPTION FACTORS; OSTEOCLASTS; PAIRED BOX TRANSCRIPTION FACTORS; RANK LIGAND; REPRESSOR PROTEINS; RESPONSE ELEMENTS;

EID: 84886715809     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.461848     Document Type: Article

References (64)

1. Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., and Martin, T. J. (1999) Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families.. Endocr. Rev. 20, 345-357
2. Karsenty, G., and Wagner, E. F. (2002) Reaching a genetic and molecular understanding of skeletal development. Dev. Cell 2, 389-406
3. Manolagas, S. C. (2000) Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis.. Endocr. Rev. 21, 115-137
4. Theill, L. E., Boyle, W. J., and Penninger, J. M. (2002) RANk-L and RANk: T cells, bone loss, and mammalian evolution. Annu. Rev. Immunol. 20, 795-823
5. Kong, Y. Y., Yoshida, H., Sarosi, I., Tan, H. L., Timms, E., Capparelli, C, Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., Khoo, W., Wakeham, A., Dunstan, C. R., Lacey, D. L., Mak, T. W., Boyle, W. J., and Penninger, J. M. (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development, and lymph-node organogenesis.. Nature 397, 315-323
6. Dougall, W. C, Glaccum, M., Charrier, K., Rohrbach, K., Brasel, K., De Smedt, T., Daro, E., Smith, J., Tometsko, M. E., Maliszewski, C. R., Armstrong, A., Shen, V., Bain, S., Cosman, D., Anderson, D., Morrissey, P. J., Peschon, J. J., and Schuh, J. (1999) RANk is essential for osteoclast and lymph node development. Genes Dev. 13, 2412-2424
7. Teitelbaum, S. L. (2000) Bone resorption by osteoclasts. Science 289, 1504-1508
8. Tondravi, M. M., Mckercher, S. R., Anderson, K., Erdmann, J. M., Quiroz, M., Maki, R., and Teitelbaum, S. L. (1997) Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature 386, 81-84
9. Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M. S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., Shimamoto, G., De Rose, M., Elliott, R., Colombero, A., Tan, H. L., Trail, G., Sullivan, J., Davy, E., Bucay, N., Renshaw-Gegg, L., Hughes, T. M., Hill, D., Pattison, W, Campbell, P., Sander, S., Van, G., Tarpley, J., Derby, P., Lee, R., Boyle, W. J. (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89, 309-319
10. Wang, Z. Q., Ovitt, C, Grigoriadis, A. E., Möhle-Steinlein, U., Rüther, U., and Wagner, E. F. (1992) Bone and haematopoietic defects in mice lacking c-fos. Nature 360, 741-745
11. Johnson, R. S., Spiegelman, B. M., and Papaioannou, V. (1992) Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell 71, 577-586
12. Franzoso, G., Carlson, L., Xing, L., Poljak, L., Shores, E. W., Brown, K. D., Leonardi, A., Tran, T., Boyce, B. F., and Siebenlist, U. (1997) Requirement for NF-κB in osteoclast and B-cell development. Genes Dev. 11, 3482-3496
13. Iotsova, V., Caamaño, J., Loy, J., Yang, Y., Lewin, A., and Bravo, R. (1997) Osteopetrosis in mice lacing NF-κB1 and NF-κB2. Nat. Med. 3, 1285-1289
14. Hodgkinson, C. A., Moore, K. J., Nakayama, A., Steingrímsson, E., Copeland, N. G., Jenkins, N. A., and Arnheiter, H. (1993) Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein.. Cell 74, 395-404
15. Matsumoto, M., Sudo, T., Saito, T., Osada, H., and Tsujimoto, M. (2000) Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-κB ligand. J. Biol. Chem. 275, 31155-31161
16. Matsumoto, M., Hisatake, K., Nogi, Y., and Tsujimoto, M. (2001) Regulation of receptor activator of NF-kB ligand-induced tartrate-resistant acid phosphatase gene expression by PU.1-interacting protein/interferon regulatory factor-4. Synergism with microphthalmia transcription factor. J. Biol. Chem. 276, 33086-33092
17. Takayanagi, H, Kim, S., Koga, T., Nishina, H, Isshiki, M., Yoshida, H, Saiura, A., Isobe, M., Yokochi, T., Inoue, J., Wagner, E. F., Mak, T. W., Kodama, T., and Taniguchi, T. (2002) Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANkL signaling in terminal differentiation of osteoclasts.. Dev. Cell 3, 889-901
18. Matsumoto, M., Kogawa, M., Wada, S., Takayanagi, H, Tsujimoto, M., Katayama, S., Hisatake, K., and Nogi, Y. (2004) Essential role of p38 mitogen-activated protein kinase in cathepsin k gene expression during osteoclastogenesis through association of NFATc1 and PU.1.. J. Biol. Chem. 279, 45969-45979
19. Bopp, D., Burri, M., Baumgartner, S., Frigerio, G., and Noll, M. (1986) Conservation of a large protein domain in the segmentation gene paired and in functionally related genes of Drosophila.. Cell 47, 1033-1040
20. Dahl, E., Koseki, H., and Balling, R. (1997) Pax genes and organogenesis. BioEssays 19, 755-765
21. Torres, M., Gómez-Pardo, E., and Gruss, P. (1996) Pax2 contributes to inner ear patterning and optic nerve trajectory. Development 122, 3381-3391
22. Conway, S. J., Bundy, J., Chen, J., Dickman, E., Rogers, R., and Will, B. M. (2000) Decreased neural crest stem cell expansion is responsible for the conotruncal heart defects within the splotch (Sp (2H))/Pax3 mouse mutant.. Cardiovasc. Res. 47, 314-328
23. -/- mutant mice. Development 122, 831-838
24. Pfeffer, P. L., Gerster, T., Lun, K., Brand, M., Busslinger, M. (1998) Characterization of three novel members of the zebrafish Pax2/5/8 family: dependency of Pax5 and Pax8 expression on the Pax2.1 (noi) function.. Development 125, 3063-3074
25. Delogu, A., Schebesta, A., Sun, Q., Aschenbrenner, K., Perlot, T., and Busslinger, M. (2006) Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells.. Immunity 24, 269-281
26. Hill, R. E., Favor, J., Hogan, B. L., Ton, C. C, Saunders, G. F., Hanson, I. M., Prosser, J., Jordan, T., Hastie, N. D., and Van Heyningen, V. (1991) Mouse small eye results from mutations in a paired-like homeobox-containing gene. Nature 354, 522-525
27. Bharti, K., Gasper, M., Ou, J., Brucato, M., Clore-Gronenborn, K., Pickel, J., and Arnheiter, H. (2012) A regulatory loop involving PAX6, MITF, and WNT signaling controls retinal pigment epithelium development.. PLoS Genet. 8, e1002757
28. Hasson, P., and Paroush, Z. (2006) Crosstalk between the EGFR and other signalling pathways at the level of the global transcriptional corepressor Groucho/TLE.. Br. J. Cancer 94, 771-775
29. Wang, W., Wang, Y. G., Reginato, A. M., Glotzer, D. J., Fukai, N, Plotkina, S., Karsenty, G., and Olsen, B. R. (2004) Groucho homologue Grg5 interacts with the transcription factor Runx2-Cbfa1 and modulates its activity during postnatal growth in mice.. Dev. Biol. 270, 364-381
30. Castori, M., Barboni, L., Duncan, P. J., Paradisi, M., Laino, L., De Bernardo, C., Robinson, D. O., and Grammatico, P. (2009) Darier disease, multiple bone cysts, and aniridia due to double de novo heterozygous mutations in ATP2A2 and PAX6.. Am. J. Med. Genet. 149, 1768-1772
31. Yasuda, H., Shima, N, Nakagawa, N, Mochizuki, S. I., Yano, K., Fujise, N, Sato, Y., Goto, M., Yamaguchi, K., Kuriyama, M., Kanno, T., Murakami, A., Tsuda, E., Morinaga, T., and Higashio, K. (1998) Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro.. Endocrinology 139, 1329-1337
32. Takayanagi, H., Ogasawara, K., Hida, S., Chiba, T., Murata, S., Sato, K., Takaoka, A., Yokochi, T., Oda, H., Tanaka, K., Nakamura, K., and Taniguchi, T. (2000) T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANkL and IFN-γ.. Nature 408, 600-605
33. Takayanagi, H., Kim, S., Matsuo, K., Suzuki, H., Suzuki, T., Sato, K., Yokochi, T., Oda, H, Nakamura, K., Ida, N, Wagner, E. F., and Taniguchi, T. (2002) RANkL maintains bone homeostasis through c-Fos-dependent induction of interferon-β. Nature 416, 744-749
34. Lee, J., Kim, K., Kim, J. H., Jin, H. M., Choi, H. K., Lee, S. H, Kook, H., Kim, K. K., Yokota, Y., Lee, S. Y., Choi, Y., and Kim, N. (2006) Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation. Blood 107, 2686-2693
35. Hikata, T., Takaishi, H, Takito, J., Hakozaki, A., Furukawa, M., Uchikawa, S., Kimura, T., Okada, Y., Matsumoto, M., Yoshimura, A., Nishimura, R., Reddy, S. V., Asahara, H., and Toyama, Y. (2009) PIAS3 negatively regulates RANkL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts.. Blood 113, 2202-2212
36. Dang, J., Inukai, T., Kurosawa, H, Goi, K., Inaba, T., Lenny, N. T., Downing, J. R., Stifani, S., and Look, A. T. (2001) The E2A-HLF oncoprotein activates Groucho-related genes and suppresses Runx1. Mol. Cell. Biol. 21, 5935-5945
37. Matsumoto, M., Sudo, T., Maruyama, M., Osada, H, and Tsujimoto, M. (2000) Activation of p38 mitogen-activated protein kinase is crucial in osteoclastogenesis induced by tumor necrosis factor.. FEBS Lett. 486, 23-28
38. Matsumoto, M., Tanaka, N, Harada, H, Kimura, T., Yokochi, T., Kitagawa, M., Schindler, C, and Taniguchi, T. (1999) Activation of the transcription factor ISGF3 by interferon-γ. Biol. Chem. 380, 699-703
39. Tanaka, S., Nakamura, K., Takahasi, N, and Suda, T. (2005) Role of RANkL in physiological and pathological bone resorption and therapeutics targeting the RANkL-RANk signaling system.. Immunol. Rev. 208, 30-49
40. Horowitz, M. C, Xi, Y., Pflugh, D. L., Hesslein, D. G., Schatz, D. G., Lorenzo, J. A., and Bothwell, A. L. (2004) Pax5-deficient mice exhibit early onset osteopenia with increased osteoclast progenitors. J. Immunol. 173, 6583-6591
41. Luchin, A., Purdom, G., Murphy, K., Clark, M. Y., Angel, N, Cassady, A. I., Hume, D. A., and Ostrowski, M. C. (2000) The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts. J. Bone Miner. Res. 15, 451-460
42. Sander, M., Neubüser, A., Kalamaras, J., Ee, H. C, Martin, G. R., and German, M. S. (1997) Genetic analysis reveals that PAX6 is required for normal transcription of pancreatic hormone genes and islet development.. Genes Dev. 11, 1662-1673
43. Glaser, T., Jepeal, L., Edwards, J. G., Young, S. R., Favor, J., and Maas, R. L. (1994) PAX6 gene dosage effect in a family with congenital cataracts, aniridia, anophthalmia and central nervous system defects.. Nat. Genet. 7, 463-471
44. St-Onge, L., Sosa-Pineda, B., Chowdhury, K., Mansouri, A., and Gruss, P. (1997) Pax6 is required for differentiation of glucagon-producing α-cells in mouse pancreas. Nature 387, 406-409
45. Epstein, J., Cai, J., Glaser, T., Jepeal, L., and Maas, R. (1994) Identification of a Pax paired domain recognition sequence and evidence for DNA-dependent conformational changes. J. Biol. Chem. 269, 8355-8361
46. Linderson, Y., Eberhard, D., Malin, S., Johansson, A., Busslinger, M., and Pettersson, S. (2004) Corecruitment of the Grg4 repressor by PU. 1 is critical for Pax5-mediated repression of B-cell-specific genes. EMBORep. 5, 291-296
47. Lang, D., Lu, M. M., Huang, L., Engleka, K. A., Zhang, M., Chu, E. Y., Lipner, S., Skoultchi, A., Millar, S. E., and Epstein, J. A. (2005) Pax3 functions at a nodal point in melanocyte stem cell differentiation. Nature 433, 884-887
48. Cai, Y., Brophy, P. D., Levitan, I., Stifani, S., and Dressler, G. R. (2003) Groucho suppresses Pax2 transactivation by inhibition of JNk-mediated phosphorylation. EMBO J. 22, 5522-5529
49. Králová, J., Czerny, T., Spanielová, H, Ratajová, V., and Kozmik, Z. (2002) Complex regulatory element within the γE- and γF-crystallin enhancers mediates Pax6 regulation and is required for induction by retinoic acid.. Gene 286, 271-282
50. Marçal, N, Patel, H, Dong, Z., Belanger-Jasmin, S., Hoffman, B., Helgason, C. D., Dang, J., and Stifani, S. (2005) Antagonistic effects of Grg6 and Groucho/TLE on the transcription repression activity of brain factor 1/FoxG1 and cortical neuron differentiation.. Mol. Cell. Biol. 25, 10916-10929
51. Hayman, A. R., Jones, S. J., Boyde, A., Foster, D., Colledge, W. H, Carlton, M. B., Evans, M. J., and Cox, T. M. (1996) Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis.. Development 122, 3151-3162
52. Luchin, A., Suchting, S., Merson, T., Rosol, T. J., Hume, D. A., Cassady, A. I., and Ostrowski, M. C. (2001) Genetic and physical interactions between Microphthalmia transcription factor and PU.1 are necessary for osteoclast gene expression and differentiation.. J. Biol. Chem. 276, 36703-36710
53. Chi, N, and Epstein, J. A. (2002) Getting your Pax straight: Pax proteins in development and disease. Trends Genet. 18, 41-47
54. Eberhard, D., Jiménez, G., Heavey, B., and Busslinger, M. (2000) Transcriptional repression by Pax5 (BSAP) through interaction with corepressors of the Groucho family.. EMBO J. 19, 2292-2303
55. Elvenes, J, Thomassen, E. I, Johnsen, S. S., Kaino, K, Sjøttem, E., and Johansen, T. (2011) Pax6 represses androgen receptor-mediated transactivation by inhibiting recruitment of the coactivator SPBP.. PLoS One 6, e24659
56. Wolf, G., Hessabi, B., Karkour, A., Henrion, U., Dahlhaus, M., Ostmann, A., Giese, B., Fraunholz, M., Grabarczyk, P., Jack, R., and Walther, R. (2010) The activation of the rat insulin gene II by BETA2 and PDX-1 in rat insulinoma cells is repressed by Pax6.. Mol. Endocrinol. 24, 2331-2342
57. Jennings, B. H., and Ish-Horowicz, D. (2008) The Groucho/TLE/Grg family of transcriptional co-repressors. Genome Biol. 9, 205
58. Fisher, A. L., and Caudy, M. (1998) Groucho proteins: transcriptional corepressors for specific subsets of DNA-binding transcription factors in vertebrates and invertebrates.. Genes Dev. 12, 1931-1940
59. Moreno, J. L., Kaczmarek, M., Keegan, A. D., and Tondravi, M. (2003) IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: irreversible inhibition of the differentiation program activated by RANkL.. Blood 102, 1078-1086
60. Wallin, J., Wilting, J., Koseki, H., Fritsch, R., Christ, B., and Balling, R. (1994) The role of Pax-1 in axial skeleton development. Development 120, 1109-1121
61. Peters, H., Neubüser, A., Kratochwil, K., and Balling, R. (1998) Pax9-deficient mice lack pharyngeal pouch derivatives and teeth and exhibit craniofacial and limb abnormalities.. Genes Dev. 12, 2735-2747
62. Hoth, C. F., Milunsky, A., Lipsky, N., Sheffer, R., Clarren, S. K., and Baldwin, C. T. (1993) Mutations in the paired domain of the human PAX3 gene cause klein-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I). Am.. J. Hum. Genet. 52, 455-462
63. Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C, Scully, S., Tan, H. L., Xu, W., Lacey, D. L., Boyle, W. J., and Simonet, W. S. (1998) Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12, 1260-1268
64. Abu-Amer, Y. (2001) IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-κB. J. Clin. Invest. 107, 1375-1385